Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)
Public ClinicalTrials.gov record NCT02790606. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective, Multi-Center Clinical Study of the Bard® COVERA™ Arteriovenous (AV) Stent Graft in the Treatment of Stenosis at the Graft-Vein Anastomosis of AV Graft Circuits (AVeVA)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to assess the safety and effectiveness of the COVERA™ Vascular Covered Stent for the treatment of stenotic lesions in the upper extremity venous outflow of the Arteriovenous (AV) access circuit.
Study identification
- NCT ID
- NCT02790606
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2016 (Actual)
- Primary completion
- Aug 2017 (Actual)
- Completion
- Mar 16, 2019 (Actual)
- Last update posted
- Apr 14, 2020
2016 – 2019
United States locations
- U.S. sites
- 16
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Kidney Disease and Hypertension Center | Phoenix | Arizona | 85012 | — |
| Southwest Vascular Center | Tempe | Arizona | 85281 | — |
| Arizona Kidney Disease and Hypertension Center Medical Research Services, LLC | Tucson | Arizona | 85712 | — |
| St. Joseph Hospital | Orange | California | 92868 | — |
| Capital Nephrology Access Center | Sacramento | California | 95815 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32207 | — |
| Ocala Kidney Group | Ocala | Florida | 34471 | — |
| Chicago Access Care | Chicago | Illinois | 60521 | — |
| Renal and Transplant Associates of New England, P.C. | West Springfield | Massachusetts | 01089 | — |
| The Cardiovascular Care Group | Westfield | New Jersey | 07090 | — |
| Surgical Specialists of Charlotte | Charlotte | North Carolina | 28207 | — |
| NC Heart and Vascular Research | Raleigh | North Carolina | 27607 | — |
| NC Nephrology | Raleigh | North Carolina | 27610 | — |
| Providence Access Care | Providence | Rhode Island | 02906 | — |
| Tarrant Vascular Clinic | Fort Worth | Texas | 76104 | — |
| Clinical Advancement Center, PLLC | San Antonio | Texas | 78215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02790606, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2020 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02790606 live on ClinicalTrials.gov.